Histone deacetylase inhibitors: Development of suberoylanilide hydroxamic acid (SAHA) for the treatment of cancers

被引:82
作者
Richon, VM
Zhou, XB
Rifkind, RA
Marks, PA
机构
[1] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10021 USA
[2] Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA
关键词
D O I
10.1006/bcmd.2000.0376
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:260 / 264
页数:5
相关论文
共 58 条
  • [41] Effect of p21WAF1/CIP1 expression on tumor progression in bladder cancer
    Stein, JP
    Ginsberg, DA
    Grossfeld, GD
    Chatterjee, SJ
    Esrig, D
    Dickinson, MG
    Groshen, S
    Taylor, CR
    Jones, PA
    Skinner, DG
    Cote, RJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (14) : 1072 - 1079
  • [42] Histone acetylation and transcriptional regulatory mechanisms
    Struhl, K
    [J]. GENES & DEVELOPMENT, 1998, 12 (05) : 599 - 606
  • [43] A mammalian histone deacetylase related to the yeast transcriptional regulator Rpd3p
    Taunton, J
    Hassig, CA
    Schreiber, SL
    [J]. SCIENCE, 1996, 272 (5260) : 408 - 411
  • [44] TURNER BM, 1993, CELL, V75, P5, DOI 10.1016/0092-8674(93)90673-E
  • [45] Cloning and characterization of human histone deacetylase 8
    Van den Wyngaert, I
    de Vries, W
    Kremer, A
    Neefs, JM
    Verhasselt, P
    Luyten, WHML
    Kass, SU
    [J]. FEBS LETTERS, 2000, 478 (1-2) : 77 - 83
  • [46] VanLint C, 1996, GENE EXPRESSION, V5, P245
  • [47] Identification of a new family of higher eukaryotic histone deacetylases - Coordinate expression of differentiation-dependent chromatin modifiers
    Verdel, A
    Khochbin, S
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (04) : 2440 - 2445
  • [48] Induction of apoptosis in U937 human leukemia cells by suberoylanilide hydroxamic acid (SAHA) proceeds through pathways that are regulated by Bcl-2/Bcl-XL, c-Jun, and p21CIP1, but independent of p53
    Vrana, JA
    Decker, RH
    Johnson, CR
    Wang, Z
    Jarvis, WD
    Richon, VM
    Ehinger, M
    Fisher, PB
    Grant, S
    [J]. ONCOGENE, 1999, 18 (50) : 7016 - 7025
  • [49] Walsh K, 1997, Prog Cell Cycle Res, V3, P53
  • [50] Wang AH, 1999, MOL CELL BIOL, V19, P7816